A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia-Reference-Cited by-同舟云学术

A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia

Published:2002-05 Issue:5 Volume:24 Page:736-751
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Gotfried Mark H.,Dattani Dan,Riffer Ernie,Devcich Karen J.,Busman Todd A.,Notario Gerard F.,Palmer Robert N.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference23 articles.

1. An update on community-acquired pneumonia in adults;Gotfried;Compr Ther,2000

2. Antibiotic usage for respiratory tract infections in an era of rising resistance and increased cost pressure;Spiritus;Am J Managed Care,2000

3. Etiology of community-acquired pneumonia: Impact of age, comorbidity, and severity;Ruiz;Am J Respir Crit Care Med,1999

4. Antimicrobial resistance in Streptococcus pneumoniae: Implications for patients with community-acquired pneumonia;Chenoweth;Mayo Clin Proc,2000

5. Importance of atypical pathogens of community-acquired pneumonia;Plouffe;Clin Infect Dis,2000

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the Best Initial Oral Antibiotics for Adults with Community-Acquired Pneumonia: A Network Meta-Analysis;Journal of General Internal Medicine;2024-02-15

2. Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology;International Journal of Antimicrobial Agents;2023-10

3. Mortality and clinical cure rates for pneumonia: a systematic review, meta-analysis, and trial sequential analysis of randomized control trials comparing bactericidal and bacteriostatic antibiotic treatments;Clinical Microbiology and Infection;2022-07

4. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America;American Journal of Respiratory and Critical Care Medicine;2019-10-01

In vitro activity and pharmacodynamic/pharmacokinetic parameters of clarithromycin and azithromycin: why they matter in the treatment of respiratory tract infections

;Infection and Drug Resistance;2019-03